BACKGROUND AND OBJECTIVES: Carrageenan-based nonoxynol-9 (N-9)-containing formulations were developed in response to the concern that over the counter (OTC) spermicides may not protect people from HIV infection and other sexually transmitted pathogens. GOAL OF THIS STUDY: The goal of this study was to compare the efficacy of carrageenan-based formulations to OTC spermicides in protecting mice from infection by herpes simplex virus 2 (HSV-2). STUDY DESIGN: Mice were challenged with vaginal inoculation of HSV-2 after pretreatment with test formulations. RESULTS: Carrageenan-based formulations were significantly more effective than currently marketed spermicides containing the same amount of N-9. Efficacy was demonstrated over a wide pH range. The carrageenan-based formulations could be autoclaved without losing antiviral activity and remained active in the vagina for several hours. CONCLUSIONS: We conclude that carrageenan-based N-9 formulations are likely to provide a more significant degree of protection against HSV-2 and other enveloped viruses than current OTC spermicides while providing comparable spermicidal activity.
BACKGROUND AND OBJECTIVES:Carrageenan-based nonoxynol-9 (N-9)-containing formulations were developed in response to the concern that over the counter (OTC) spermicides may not protect people from HIV infection and other sexually transmitted pathogens. GOAL OF THIS STUDY: The goal of this study was to compare the efficacy of carrageenan-based formulations to OTC spermicides in protecting mice from infection by herpes simplex virus 2 (HSV-2). STUDY DESIGN:Mice were challenged with vaginal inoculation of HSV-2 after pretreatment with test formulations. RESULTS:Carrageenan-based formulations were significantly more effective than currently marketed spermicides containing the same amount of N-9. Efficacy was demonstrated over a wide pH range. The carrageenan-based formulations could be autoclaved without losing antiviral activity and remained active in the vagina for several hours. CONCLUSIONS: We conclude that carrageenan-based N-9 formulations are likely to provide a more significant degree of protection against HSV-2 and other enveloped viruses than current OTC spermicides while providing comparable spermicidal activity.
Authors: José A Fernández-Romero; Ciby J Abraham; Aixa Rodriguez; Larisa Kizima; Ninochka Jean-Pierre; Radhika Menon; Othell Begay; Samantha Seidor; Brian E Ford; Pedro I Gil; Jennifer Peters; David Katz; Melissa Robbiani; Thomas M Zydowsky Journal: Antimicrob Agents Chemother Date: 2011-11-07 Impact factor: 5.191
Authors: Toral Zaveri; Cordelia A Running; Lahari Surapaneni; Gregory R Ziegler; John E Hayes Journal: Drug Deliv Transl Res Date: 2016-10 Impact factor: 4.617
Authors: Bonnie E Lai; Anthony R Geonnotti; Michael G Desoto; David C Montefiori; David F Katz Journal: Antiviral Res Date: 2010-08-13 Impact factor: 5.970
Authors: Victor B Hsue; Kyohei Itamura; Arthur W Wu; Elisa A Illing; Kevin J Sokoloski; Bree A Weaver; Benjamin P Anthony; Nathan Hughes; Jonathan Y Ting; Thomas S Higgins Journal: Adv Exp Med Biol Date: 2021 Impact factor: 2.622
Authors: Stuart G Turville; Meropi Aravantinou; Todd Miller; Jessica Kenney; Aaron Teitelbaum; Lieyu Hu; Anne Chudolij; Tom M Zydowsky; Michael Piatak; Julian W Bess; Jeffrey D Lifson; James Blanchard; Agegnehu Gettie; Melissa Robbiani Journal: PLoS One Date: 2008-09-08 Impact factor: 3.240